These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 20136915)

  • 1. Unusual presentation of tuberculosis in an infliximab-treated patient--which is the correct TB screening before starting a biologic?
    Gori A; Fabroni C; Prignano F; Lotti T
    Dermatol Ther; 2010; 23 Suppl 1():S1-3. PubMed ID: 20136915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of latent tuberculosis infection in patients with moderate to severe psoriasis taking biologic therapies in a dermatologic private practice in Miami, Florida.
    Medina-Gil C; Dehesa L; Vega A; Kerdel F
    Int J Dermatol; 2015 Jul; 54(7):846-52. PubMed ID: 26108266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of cervical tuberculous lymphadenitis in a patient with Crohn's disease receiving infliximab despite of chemoprophylaxis with isoniazid].
    Ikeue T; Nakagawa A; Furuta K; Morita K; Sugita T; Nishiyama H
    Kekkaku; 2011 Nov; 86(11):879-82. PubMed ID: 22250467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of tuberculosis infection in psoriatic patients on anti-TNF therapy: report of a case series with 144 patients.
    Sánchez-Moya AI; Dauden E
    J Eur Acad Dermatol Venereol; 2011 Jun; 25(6):730-3. PubMed ID: 21564322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug resistant miliary tuberculosis during infliximab therapy despite tuberculosis screening.
    Gin A; Dolianitis C
    Australas J Dermatol; 2014 May; 55(2):140-1. PubMed ID: 23713793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection and management of latent tuberculosis infections before biologic therapy for psoriasis.
    Amerio P; Amoruso G; Bardazzi F; Campanati A; Cassano N; Conti A; Gisondi P; Guarneri C; Mazzotta A; Piaserico S; Prestinari F; Prignano F; Zane C; de Simone C
    J Dermatolog Treat; 2013 Aug; 24(4):305-11. PubMed ID: 22208431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-γ release assay for tuberculosis in patients with psoriasis treated with tumour necrosis factor antagonists: in vivo and in vitro analysis.
    Sauzullo I; Mengoni F; Marocco R; Potenza C; Skroza N; Tieghi T; Lichtner M; Vullo V; Mastroianni CM
    Br J Dermatol; 2013 Nov; 169(5):1133-40. PubMed ID: 23909256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of tuberculosis with the use of anti-TNF medications in psoriasis: incidence, screening and management.
    Kasiraman V; Atwan AA; Durojaiye OC; Kalavala M; Piguet V
    Dermatol Online J; 2014 Aug; 20(8):. PubMed ID: 25148273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of QuantiFERON®-TB Gold test in psoriatic patients under treatment with tumour necrosis factor blockers.
    Saraceno R; Specchio F; Chiricozzi A; Sarmati L; Amicosante M; Chimenti MS; Chimenti S
    Expert Opin Biol Ther; 2014 Feb; 14(2):151-6. PubMed ID: 24303977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of single and dual latent tuberculosis screening strategies before biologic and targeted therapy in patients with rheumatic diseases: a retrospective cohort study.
    Tang I; So H; Luk L; Wong V; Pang S; Lao V; Yip R
    Hong Kong Med J; 2020 Apr; 26(2):111-119. PubMed ID: 32245912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of long-term therapy with biological drugs in psoriatic patients with latent tuberculosis infection in real life setting.
    Conti A; Piaserico S; Gisondi P; Odorici G; Galdo G; Lasagni C; Pellacani G
    Dermatol Ther; 2017 Sep; 30(5):. PubMed ID: 28547750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Splenic tuberculosis during psoriasis treatment with infliximab].
    Fortaleza GT; Brito Mde F; Santos JB; Figueiredo AR; Gomes P
    An Bras Dermatol; 2009; 84(4):420-4. PubMed ID: 19851677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberculosis among asylum seekers in Milan, Italy: epidemiological analysis and evaluation of interventions.
    Villa S; Codecasa LR; Faccini M; Pontello MM; Ferrarese M; Castellotti PF; Senatore S; Lamberti A; Mazzola E; Perno CF; Campisi D; Saporiti M; Raviglione MC
    Eur Respir J; 2019 Oct; 54(4):. PubMed ID: 31413161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of latent tuberculosis reactivation in a patient treated with ustekinumab without concomitant isoniazid chemoprophylaxis in the PEARL trial.
    Tsai TF; Chiu HY; Song M; Chan D
    Br J Dermatol; 2013 Feb; 168(2):444-6. PubMed ID: 22816505
    [No Abstract]   [Full Text] [Related]  

  • 15. A prospective cohort study of latent tuberculosis in adult close contacts of active pulmonary tuberculosis patients in Korea.
    Park SH; Lee SJ; Cho YJ; Jeong YY; Kim HC; Lee JD; Kim HJ; Menzies D
    Korean J Intern Med; 2016 May; 31(3):517-24. PubMed ID: 27052266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of Treatment for Latent Tuberculosis Infection in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy.
    Ramos GP; Stroh G; Al-Bawardy B; Faubion WA; Papadakis KA; Escalante P
    Inflamm Bowel Dis; 2018 Sep; 24(10):2272-2277. PubMed ID: 29718223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biologic therapy for inflammatory arthritis and latent tuberculosis: real world experience from a high prevalence area in the United Kingdom.
    Nisar MK; Rafiq A; Östör AJ
    Clin Rheumatol; 2015 Dec; 34(12):2141-5. PubMed ID: 26497501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Latent tuberculosis infection in patients with chronic plaque psoriasis who are candidates for biological therapy.
    Gisondi P; Pezzolo E; Lo Cascio G; Girolomoni G
    Br J Dermatol; 2014 Oct; 171(4):884-90. PubMed ID: 24863903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re-activation of bovine tuberculosis in a patient treated with infliximab.
    Larsen MV; Sørensen IJ; Thomsen VØ; Ravn P
    Eur Respir J; 2008 Jul; 32(1):229-31. PubMed ID: 18591340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous Mycobacterium haemophilum infection in a patient receiving infliximab for psoriasis.
    Aslam A; Green RL; Motta L; Ghrew M; Griffiths CE; Warren RB
    Br J Dermatol; 2013 Feb; 168(2):446-7. PubMed ID: 22816532
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.